Recent Insider Transactions • May 14
VP of Sales & Marketing and Director recently bought ₱468k worth of stock On the 8th of May, Hans Joseph Perez bought around 277k shares on-market at roughly ₱1.69 per share. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₱684k. Insiders have collectively bought ₱9.6m more in shares than they have sold in the last 12 months. Recent Insider Transactions • May 06
Non-Executive Director recently sold ₱676k worth of stock On the 4th of May, Eugene H. Villanueva sold around 400k shares on-market at roughly ₱1.69 per share. This transaction amounted to 1.2% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₱850k. Despite this recent sale, insiders have collectively bought ₱9.2m more than they sold in the last 12 months. Recent Insider Transactions • May 02
Non-Executive Director recently sold ₱850k worth of stock On the 23rd of April, Eugene H. Villanueva sold around 500k shares on-market at roughly ₱1.70 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought ₱8.5m more than they sold in the last 12 months. Recent Insider Transactions • Apr 30
VP of Sales & Marketing and Director recently bought ₱210k worth of stock On the 22nd of April, Hans Joseph Perez bought around 123k shares on-market at roughly ₱1.71 per share. This transaction amounted to 1.7% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₱850k. Insiders have collectively bought ₱8.9m more in shares than they have sold in the last 12 months. Reported Earnings • Apr 17
Full year 2025 earnings released: EPS: ₱0.25 (vs ₱0.32 in FY 2024) Full year 2025 results: EPS: ₱0.25 (down from ₱0.32 in FY 2024). Revenue: ₱1.16b (down 22% from FY 2024). Net income: ₱151.6m (down 21% from FY 2024). Profit margin: 13% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Declared Dividend • Mar 14
Dividend of ₱0.10 announced Dividend of ₱0.10 is the same as last year. Ex-date: 24th March 2026 Payment date: 15th April 2026 Dividend yield will be 5.8%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is well covered by both earnings (43% earnings payout ratio) and cash flows (34% cash payout ratio). The dividend has increased by an average of 19% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Tillkännagivande • Mar 13
Crown Asia Chemicals Corporation announces Annual dividend, payable on April 15, 2026 Crown Asia Chemicals Corporation announced Annual dividend of PHP 0.1000 per share payable on April 15, 2026, ex-date on March 24, 2026 and record date on March 25, 2026. Tillkännagivande • Mar 11
Crown Asia Chemicals Corporation, Annual General Meeting, May 14, 2026 Crown Asia Chemicals Corporation, Annual General Meeting, May 14, 2026, at 15:00 W. Australia Standard Time. Location: via videconference in accordance with the rules of, Philippines Recent Insider Transactions • Feb 04
President & Director recently bought ₱850k worth of stock On the 2nd of February, Derrick Villanueva bought around 500k shares on-market at roughly ₱1.70 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱1.7m. Derrick has been a buyer over the last 12 months, purchasing a net total of ₱2.5m worth in shares. Recent Insider Transactions • Nov 27
VP of Sales & Marketing and Director recently bought ₱165k worth of stock On the 25th of November, Hans Joseph Perez bought around 100k shares on-market at roughly ₱1.65 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱340k. Insiders have collectively bought ₱7.0m more in shares than they have sold in the last 12 months. Reported Earnings • Nov 16
Third quarter 2025 earnings released: EPS: ₱0.07 (vs ₱0.08 in 3Q 2024) Third quarter 2025 results: EPS: ₱0.07 (down from ₱0.08 in 3Q 2024). Revenue: ₱323.0m (down 17% from 3Q 2024). Net income: ₱44.8m (down 4.4% from 3Q 2024). Profit margin: 14% (up from 12% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Recent Insider Transactions • Oct 23
VP of Sales & Marketing and Director recently bought ₱340k worth of stock On the 20th of October, Hans Joseph Perez bought around 212k shares on-market at roughly ₱1.61 per share. This transaction amounted to 3.2% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱5.2m. Insiders have collectively bought ₱6.8m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Oct 07
Non-Executive Director recently sold ₱86k worth of stock On the 3rd of October, Eugene H. Villanueva sold around 51k shares on-market at roughly ₱1.68 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought ₱6.6m more than they sold in the last 12 months. Recent Insider Transactions • Sep 16
VP of Sales & Marketing and Director recently bought ₱76k worth of stock On the 10th of September, Hans Joseph Perez bought around 46k shares on-market at roughly ₱1.64 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱5.2m. Insiders have collectively bought ₱6.6m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Aug 19
Chairman of the Board recently sold ₱83k worth of stock On the 12th of August, Walter Villanueva sold around 50k shares on-market at roughly ₱1.66 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Walter has been a net seller over the last 12 months, reducing personal holdings by ₱89k. Reported Earnings • Aug 09
Second quarter 2025 earnings released: EPS: ₱0.05 (vs ₱0.09 in 2Q 2024) Second quarter 2025 results: EPS: ₱0.05 (down from ₱0.09 in 2Q 2024). Revenue: ₱265.1m (down 33% from 2Q 2024). Net income: ₱32.1m (down 41% from 2Q 2024). Profit margin: 12% (down from 14% in 2Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Recent Insider Transactions • Jul 10
GM of PP-R/ HDPE Pipes Division recently bought ₱347k worth of stock On the 7th of July, Hans Joseph Perez bought around 204k shares on-market at roughly ₱1.70 per share. This transaction amounted to 8.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₱345k more in shares than they have sold in the last 12 months. Reported Earnings • May 10
First quarter 2025 earnings released: EPS: ₱0.07 (vs ₱0.12 in 1Q 2024) First quarter 2025 results: EPS: ₱0.07 (down from ₱0.12 in 1Q 2024). Revenue: ₱300.6m (down 30% from 1Q 2024). Net income: ₱45.2m (down 35% from 1Q 2024). Profit margin: 15% (down from 16% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 3% per year. Reported Earnings • Mar 18
Full year 2024 earnings released: EPS: ₱0.32 (vs ₱0.41 in FY 2023) Full year 2024 results: EPS: ₱0.32 (down from ₱0.41 in FY 2023). Revenue: ₱1.49b (down 1.0% from FY 2023). Net income: ₱192.3m (down 22% from FY 2023). Profit margin: 13% (down from 16% in FY 2023). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 2% per year. Upcoming Dividend • Mar 14
Upcoming dividend of ₱0.10 per share Eligible shareholders must have bought the stock before 21 March 2025. Payment date: 16 April 2025. Payout ratio is a comfortable 29% but the company is paying out more than the cash it is generating. Trailing yield: 5.9%. Lower than top quartile of Filipino dividend payers (6.7%). Higher than average of industry peers (2.2%). Reported Earnings • Nov 17
Third quarter 2024 earnings released: EPS: ₱0.08 (vs ₱0.16 in 3Q 2023) Third quarter 2024 results: EPS: ₱0.08 (down from ₱0.16 in 3Q 2023). Revenue: ₱390.8m (down 14% from 3Q 2023). Net income: ₱46.9m (down 52% from 3Q 2023). Profit margin: 12% (down from 22% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 2% per year. Reported Earnings • Aug 10
Second quarter 2024 earnings released: EPS: ₱0.09 (vs ₱0.09 in 2Q 2023) Second quarter 2024 results: EPS: ₱0.09 (in line with 2Q 2023). Revenue: ₱395.2m (flat on 2Q 2023). Net income: ₱54.7m (flat on 2Q 2023). Profit margin: 14% (in line with 2Q 2023). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 4% per year. Upcoming Dividend • May 20
Upcoming dividend of ₱0.10 per share Eligible shareholders must have bought the stock before 27 May 2024. Payment date: 11 June 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 4.4%. Lower than top quartile of Filipino dividend payers (5.8%). Higher than average of industry peers (2.2%). Reported Earnings • May 16
First quarter 2024 earnings released: EPS: ₱0.11 (vs ₱0.092 in 1Q 2023) First quarter 2024 results: EPS: ₱0.11 (up from ₱0.092 in 1Q 2023). Revenue: ₱426.6m (up 30% from 1Q 2023). Net income: ₱70.0m (up 25% from 1Q 2023). Profit margin: 16% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 15
Crown Asia Chemicals Corporation Approves Cash Dividend, Payable on 11 June 2024 Crown Asia Chemicals Corporation announced that in a meeting held on May 14, 2024, the Corporation's Board of Directors, upon recommendation of Management, approved the declaration of cash dividends amounting to PHP 0.10 per share. Conformably with the rules of the Commission and the Philippine Stock Exchange, the Record Date and Payment Date of the foregoing cash dividend declaration shall be 28 May 2024 and 11 June 2024, respectively. Source of Dividend Payment: Unrestricted Retained Earnings as of 31 December 2023. Recent Insider Transactions • Mar 28
GM of PP-R/ HDPE Pipes Division recently bought ₱103k worth of stock On the 21st of March, Hans Joseph Perez bought around 60k shares on-market at roughly ₱1.72 per share. This transaction amounted to 2.4% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₱110k more in shares than they have sold in the last 12 months. Reported Earnings • Mar 15
Full year 2023 earnings released: EPS: ₱0.41 (vs ₱0.38 in FY 2022) Full year 2023 results: EPS: ₱0.41 (up from ₱0.38 in FY 2022). Revenue: ₱1.51b (down 14% from FY 2022). Net income: ₱247.8m (up 8.3% from FY 2022). Profit margin: 16% (up from 13% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Tillkännagivande • Mar 06
Crown Asia Chemicals Corporation, Annual General Meeting, May 09, 2024 Crown Asia Chemicals Corporation, Annual General Meeting, May 09, 2024, at 15:00 Singapore Standard Time. Agenda: To consider Call to Order; to consider Proof of Notice of Meeting; to consider Certification of Quorum; to consider Approval of the Minutes of the Previous Annual Stockholders' Meeting; to consider Approval of 2023 Operations and Results; to consider Ratification of all Acts of the Board of Directors and Management from the date of the last Annual Stockholders' Meeting to the date of this meeting; to consider Election of Directors for 2024 - 2025; to consider Appointment of External Auditors; to consider Other Matters; and to consider adjournment. Reported Earnings • Nov 12
Third quarter 2023 earnings released: EPS: ₱0.16 (vs ₱0.12 in 3Q 2022) Third quarter 2023 results: EPS: ₱0.16 (up from ₱0.12 in 3Q 2022). Revenue: ₱452.0m (down 3.8% from 3Q 2022). Net income: ₱97.7m (up 35% from 3Q 2022). Profit margin: 22% (up from 15% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Upcoming Dividend • Aug 23
Upcoming dividend of ₱0.04 per share at 5.2% yield Eligible shareholders must have bought the stock before 30 August 2023. Payment date: 25 September 2023. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 5.2%. Lower than top quartile of Filipino dividend payers (5.5%). Higher than average of industry peers (2.7%). Upcoming Dividend • Aug 18
Upcoming dividend of ₱0.04 per share at 6.0% yield Eligible shareholders must have bought the stock before 25 August 2023. Payment date: 25 September 2023. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 6.0%. Within top quartile of Filipino dividend payers (5.5%). Higher than average of industry peers (2.6%). Reported Earnings • Aug 06
Second quarter 2023 earnings released: EPS: ₱0.09 (vs ₱0.085 in 2Q 2022) Second quarter 2023 results: EPS: ₱0.09 (up from ₱0.085 in 2Q 2022). Revenue: ₱394.5m (down 6.7% from 2Q 2022). Net income: ₱54.4m (up 4.4% from 2Q 2022). Profit margin: 14% (up from 12% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • May 07
First quarter 2023 earnings released: EPS: ₱0.09 (vs ₱0.12 in 1Q 2022) First quarter 2023 results: EPS: ₱0.09 (down from ₱0.12 in 1Q 2022). Revenue: ₱329.5m (down 36% from 1Q 2022). Net income: ₱56.2m (down 26% from 1Q 2022). Profit margin: 17% (up from 15% in 1Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Upcoming Dividend • Mar 24
Upcoming dividend of ₱0.05 per share at 6.4% yield Eligible shareholders must have bought the stock before 31 March 2023. Payment date: 03 May 2023. Payout ratio is a comfortable 27% and this is well supported by cash flows. Trailing yield: 6.4%. Within top quartile of Filipino dividend payers (5.3%). Higher than average of industry peers (2.8%). Reported Earnings • Mar 23
Full year 2022 earnings released: EPS: ₱0.37 (vs ₱0.37 in FY 2021) Full year 2022 results: EPS: ₱0.37 (up from ₱0.37 in FY 2021). Revenue: ₱1.76b (up 1.1% from FY 2021). Net income: ₱228.9m (up 2.0% from FY 2021). Profit margin: 13% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Feb 25
GM of PVC Pipes Division & Director recently bought ₱186k worth of stock On the 21st of February, Derrick Villanueva bought around 117k shares on-market at roughly ₱1.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₱3.3m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Feb 16
Chairman of the Board recently bought ₱79k worth of stock On the 9th of February, Walter Villanueva bought around 50k shares on-market at roughly ₱1.59 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱151k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱3.3m worth in shares. Recent Insider Transactions • Nov 22
Chairman of the Board recently bought ₱115k worth of stock On the 17th of November, Walter Villanueva bought around 80k shares on-market at roughly ₱1.44 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱732k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱3.3m worth in shares. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Fernando Lopez was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment improved over the past week After last week's 19% share price gain to ₱1.67, the stock trades at a trailing P/E ratio of 4.5x. Average trailing P/E is 16x in the Chemicals industry in Asia. Total loss to shareholders of 11% over the past three years. Recent Insider Transactions • Sep 01
Chairman of the Board recently bought ₱236k worth of stock On the 26th of August, Walter Villanueva bought around 175k shares on-market at roughly ₱1.35 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₱632k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱2.3m worth in shares. Tillkännagivande • Aug 19
Crown Asia Chemicals Corporation Announces Resignation of Bede Lovell S. Gomez as Independent Director Crown Asia Chemicals Corporation announced that Mr. Bede Lovell S. Gomez has resigned as independent director of the company, effective immediately, in view of his acceptance of his appointment to the Government Service Insurance System. Reported Earnings • Aug 11
Second quarter 2022 earnings released: EPS: ₱0.09 (vs ₱0.12 in 2Q 2021) Second quarter 2022 results: EPS: ₱0.09 (down from ₱0.12 in 2Q 2021). Revenue: ₱422.9m (down 9.7% from 2Q 2021). Net income: ₱52.1m (down 26% from 2Q 2021). Profit margin: 12% (down from 15% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Aug 09
Chairman of the Board recently bought ₱70k worth of stock On the 3rd of August, Walter Villanueva bought around 50k shares on-market at roughly ₱1.40 per share. In the last 3 months, they made an even bigger purchase worth ₱632k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱2.1m worth in shares. Recent Insider Transactions • Jul 30
Chairman of the Board recently bought ₱632k worth of stock On the 26th of July, Walter Villanueva bought around 450k shares on-market at roughly ₱1.40 per share. This was the largest purchase by an insider in the last 3 months. Walter has been a buyer over the last 12 months, purchasing a net total of ₱2.1m worth in shares. Recent Insider Transactions • Jun 28
Chairman of the Board recently bought ₱85k worth of stock On the 22nd of June, Walter Villanueva bought around 50k shares on-market at roughly ₱1.70 per share. In the last 3 months, they made an even bigger purchase worth ₱175k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱2.8m worth in shares. Upcoming Dividend • Jun 16
Upcoming dividend of ₱0.05 per share Eligible shareholders must have bought the stock before 23 June 2022. Payment date: 19 July 2022. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of Filipino dividend payers (4.9%). Higher than average of industry peers (2.4%). Tillkännagivande • May 13
Crown Asia Chemicals Corporation Appoints Bede Lovell S. Gomez as Lead Independent Director Crown Asia Chemicals Corporation at it's organizational Meeting held on 12 May 2022 appointed Mr. Bede Lovell S. Gomez as Lead Independent Director. Reported Earnings • May 12
First quarter 2022 earnings released: EPS: ₱0.12 (vs ₱0.09 in 1Q 2021) First quarter 2022 results: EPS: ₱0.12 (up from ₱0.09 in 1Q 2021). Revenue: ₱514.6m (up 26% from 1Q 2021). Net income: ₱75.6m (up 38% from 1Q 2021). Profit margin: 15% (up from 13% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Lead Independent Director Bede Gomez was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Mar 15
Upcoming dividend of ₱0.05 per share Eligible shareholders must have bought the stock before 22 March 2022. Payment date: 19 April 2022. Payout ratio is a comfortable 5.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Filipino dividend payers (4.3%). Lower than average of industry peers (2.0%). Recent Insider Transactions • Feb 18
Non-Executive Director recently sold ₱27m worth of stock On the 16th of February, Eugene H. Villanueva sold around 405k shares on-market at roughly ₱66.37 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₱29m more than they bought in the last 12 months. Recent Insider Transactions • Nov 20
Non-Executive Director recently sold ₱334k worth of stock On the 16th of November, Eugene H. Villanueva sold around 191k shares on-market at roughly ₱1.75 per share. In the last 3 months, they made an even bigger sale worth ₱12m. Insiders have been net sellers, collectively disposing of ₱5.2m more than they bought in the last 12 months. Recent Insider Transactions • Oct 29
Non-Executive Director recently sold ₱12m worth of stock On the 26th of October, Eugene H. Villanueva sold around 7m shares on-market at roughly ₱1.66 per share. In the last 3 months, they made an even bigger sale worth ₱13m. Insiders have been net sellers, collectively disposing of ₱13m more than they bought in the last 12 months. Recent Insider Transactions • Aug 21
Non-Executive Director recently sold ₱13m worth of stock On the 17th of August, Eugene H. Villanueva sold around 8m shares on-market at roughly ₱1.70 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought ₱2.4m more than they sold in the last 12 months. Recent Insider Transactions • Aug 03
GM of PVC Pipes Division & Director recently bought ₱611k worth of stock On the 27th of July, Derrick Villanueva bought around 366k shares on-market at roughly ₱1.67 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₱743k. Insiders have collectively bought ₱5.6m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Jul 24
Chairman of the Board recently bought ₱84k worth of stock On the 21st of July, Walter Villanueva bought around 50k shares on-market at roughly ₱1.69 per share. In the last 3 months, they made an even bigger purchase worth ₱743k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱3.5m worth in shares. Recent Insider Transactions • Jul 06
Chairman of the Board recently bought ₱143k worth of stock On the 30th of June, Walter Villanueva bought around 81k shares on-market at roughly ₱1.76 per share. In the last 3 months, they made an even bigger purchase worth ₱696k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱2.0m worth in shares. Recent Insider Transactions • Jun 23
Chairman of the Board recently bought ₱88k worth of stock On the 17th of June, Walter Villanueva bought around 50k shares on-market at roughly ₱1.77 per share. In the last 3 months, they made an even bigger purchase worth ₱696k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱1.9m worth in shares. Recent Insider Transactions • Jun 17
Chairman of the Board recently sold ₱89k worth of stock On the 8th of June, Walter Villanueva sold around 49k shares on-market at roughly ₱1.81 per share. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Walter has been a buyer over the last 12 months, purchasing a net total of ₱1.8m worth of shares. Upcoming Dividend • May 13
Upcoming dividend of ₱0.022 per share Eligible shareholders must have bought the stock before 20 May 2021. Payment date: 15 June 2021. Trailing yield: 2.2%. Lower than top quartile of Filipino dividend payers (4.4%). Higher than average of industry peers (1.7%). Recent Insider Transactions • May 04
Chairman of the Board recently bought ₱54k worth of stock On the 26th of April, Walter Villanueva bought around 30k shares on-market at roughly ₱1.80 per share. In the last 3 months, they made an even bigger purchase worth ₱276k. Walter has been a buyer over the last 12 months, purchasing a net total of ₱559k worth in shares. Recent Insider Transactions • Apr 13
Chairman of the Board recently bought ₱276k worth of stock On the 5th of April, Walter Villanueva bought around 150k shares on-market at roughly ₱1.84 per share. This was the largest purchase by an insider in the last 3 months. Walter has been a buyer over the last 12 months, purchasing a net total of ₱503k worth in shares. Reported Earnings • Mar 19
Full year 2020 earnings released: EPS ₱0.20 (vs ₱0.22 in FY 2019) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: ₱1.12b (down 22% from FY 2019). Net income: ₱121.2m (down 11% from FY 2019). Profit margin: 11% (up from 9.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 1% per year. Tillkännagivande • Mar 04
Crown Asia Chemicals Corporation, Annual General Meeting, May 14, 2021 Crown Asia Chemicals Corporation, Annual General Meeting, May 14, 2021. Agenda: To consider approval of 2020 Operations and Results; to consider ratification of all Acts of the Board of Directors and Management from the date of the last Annual Stockholders' Meeting to the date of this meeting; to consider election of Directors for 2021 - 2022; to consider appointment of External Auditors; Other Matters. Recent Insider Transactions • Feb 24
Chairman of the Board recently sold ₱94k worth of stock On the 17th of February, Walter Villanueva sold around 40k shares on-market at roughly ₱2.35 per share. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Walter has been a buyer over the last 12 months, purchasing a net total of ₱217k worth of shares. Tillkännagivande • Feb 24
Crown Asia Chemicals Builds Up Partnerships Amid the adverse effects on the economy by the Covid-19 pandemic, Crown Asia Chemicals Corporation (CROWN) continues to supply its brand of high quality pipes to key infrastructure projects. This is in line with the renewed drive and collaboration of the Philippine government and private sectors for robust growth and economic development in the country. Crown Asia Chemicals Corporation has began supplying Phase 2 of the North South Railway (NSR) Project from Malolos, Bulacan to New Clark City in Tarlac, passing through the Clark International Airport in Mabalacat, Pampanga. The NSR commuter railway is aimed to provide critical connectivity through world class passenger rail service. Work for Phase 1 which runs from Tutuban to Malolos is about to start. The 91 kilometer stretch for Phases 1 and 2 will have 10 stations located at Tutuban, Solis, Caloocan, Valenzuela, Mecauayan, Marilao, Bocaue, Balagtas, Guiguinto and Malolos. Crown Pipes were and are continuously being supplied to the Metro Manila Skyway Stage 3, an 18.83 kilometer-elevated expressway from Buendia, Makati City to North Luzon Expressway in Balintawak, Quezon City. This project connects South Luzon Expressway (SLEX) and North Luzon Expressway (NLEX). This is expected to decongest traffic along EDSA, C5 and Central Metro Manila as already felt by commuters. Crown Asia Chemicals also started to supply MRT-7, another elevated railway line of 23 kilometers with 14 stations from San Jose del Monte in Bulacan to MRT3 in North Avenue, Quezon City. It has a 22-kilometer asphalt road component from Bocaue Interchange of NLEX to the intermodal terminal in Tala that will divert Northern provincial buses operation to San Jose del Monte. It will be ready by December 2021. Crown Pipes fully supplied NAIA Expressways which started in January 2014 and was operational by June 2017. The 11.6 kilometer elevated expressway system links the skyway to the Ninoy Aquino International Airport and Entertainment City. NAIAx is the first airport expressway in the Philippines. These are just some of the Crown project partnerships for economic progress, moving population, goods and services to uplift the lives of more Filipinos. Is New 90 Day High Low • Feb 17
New 90-day high: ₱2.07 The company is up 9.0% from its price of ₱1.90 on 19 November 2020. The Filipino market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 16% over the same period. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improved over the past week After last week's 16% share price gain to ₱2.07, the stock is trading at a trailing P/E ratio of 15.7x, up from the previous P/E ratio of 13.6x. This compares to an average P/E of 21x in the Chemicals industry in Asia. Total returns to shareholders over the past three years are 22%. Recent Insider Transactions • Jan 10
President recently bought ₱160k worth of stock On the 5th of January, Walter Villanueva bought around 90k shares on-market at roughly ₱1.78 per share. This was the largest purchase by an insider in the last 3 months. Walter has been a buyer over the last 12 months, purchasing a net total of ₱210k worth in shares. Is New 90 Day High Low • Dec 28
New 90-day low: ₱1.83 The company is down 4.0% from its price of ₱1.90 on 30 September 2020. The Filipino market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. Is New 90 Day High Low • Dec 09
New 90-day low: ₱1.87 The company is down 6.0% from its price of ₱1.98 on 11 September 2020. The Filipino market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 20
Third quarter 2020 earnings released: EPS ₱0.04 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₱318.4m (down 17% from 3Q 2019). Net income: ₱26.9m (down 39% from 3Q 2019). Profit margin: 8.5% (down from 12% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year. Is New 90 Day High Low • Oct 15
New 90-day high: ₱2.01 The company is up 15% from its price of ₱1.75 on 17 July 2020. The Filipino market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. 
